{"id":25110,"date":"2024-03-23T16:29:01","date_gmt":"2024-03-23T16:29:01","guid":{"rendered":"https:\/\/medgyd.lt\/cc\/human-coagulation-factor-viii-inhibitor-bypassing-fraction-baxalta-feiba-500-v-milteliai-ir-tirpiklis-injekciniam-ar-infuziniam-tirpalui-milteliai-flakonas-tirpiklio-10-ml-baxject-komplektas\/"},"modified":"2024-03-23T16:29:06","modified_gmt":"2024-03-23T16:29:06","slug":"human-coagulation-factor-viii-inhibitor-bypassing-fraction-baxalta-feiba-500-v-milteliai-ir-tirpiklis-injekciniam-ar-infuziniam-tirpalui-milteliai-flakonas-tirpiklio-10-ml-baxject-komplektas","status":"publish","type":"post","link":"https:\/\/medgyd.lt\/cc\/human-coagulation-factor-viii-inhibitor-bypassing-fraction-baxalta-feiba-500-v-milteliai-ir-tirpiklis-injekciniam-ar-infuziniam-tirpalui-milteliai-flakonas-tirpiklio-10-ml-baxject-komplektas\/","title":{"rendered":"Human coagulation factor VIII (inhibitor bypassing fraction) Baxalta [FEIBA] 500 V milteliai ir tirpiklis injekciniam ar infuziniam tirpalui milteliai, flakonas tirpiklio (10 ml), (BaxJect komplektas, injekcin\u0117 adata, injekcinis \u0161virk\u0161tas, \u201cpeteli\u0161k\u0117s\u201c tipo adata su spaustuku), N1"},"content":{"rendered":"<h1>Detali informacija apie Human coagulation factor VIII (inhibitor bypassing fraction) Baxalta [FEIBA] 500 V<\/h1>\n<p>&nbsp;<\/p>\n<p><strong>Veiklioji med\u017eiaga:<\/strong> VIII koaguliacijos faktoriaus antiinhibitoriaus-koagulianto kompleksas<\/p>\n<p><strong>Veikliosios med\u017eiagos koncentracija:<\/strong> 500 V<\/p>\n<p><strong>Vartojimo b\u016bdas:<\/strong> leisti \u012f ven\u0105<\/p>\n<p><strong>Vaistinio preparato grup\u0117:<\/strong> Vaistinis preparatas<\/p>\n<p><strong>Kitos vaisto dozuot\u0117s: <\/strong>milteliai, flakonas tirpiklio (10 ml), (BaxJect komplektas, injekcin\u0117 adata, injekcinis \u0161virk\u0161tas, \u201cpeteli\u0161k\u0117s\u201c tipo adata su spaustuku), N1, milteliai, flakonas tirpiklio (10 ml), (filtravimo adata, perpylimo adata, aeracijos adata, injekcin\u0117 adata, injekcinis \u0161virk\u0161tas, \u201cpeteli\u0161k\u0117s\u201c tipo adata su spaustuku), N1<strong><br \/>\n<\/strong><\/p>\n<p><strong>Vaistinio preparato pogrupis:<\/strong> Biologinis<\/p>\n<p><strong>Recepto poreikis:<\/strong> Receptinis<\/p>\n<p><strong>Preparato ATC kodas:<\/strong> B02BD03<\/p>\n<p><strong>Pakuot\u0117s tipas:<\/strong> flakonas<\/p>\n<p><strong>Dozuot\u0117 pakuot\u0117je:<\/strong> milteliai, flakonas tirpiklio (10 ml), (BaxJect komplektas, injekcin\u0117 adata, injekcinis \u0161virk\u0161tas, \u201cpeteli\u0161k\u0117s\u201c tipo adata su spaustuku), N1<\/p>\n<p><strong>Vaisto stadija:<\/strong> Perregistruotas 1996-02-15 LT\/1\/96\/1046\/006<\/p>\n<p><strong>Registruotojas: <\/strong>Baxalta Innovations GmbH.<\/p>\n<p><strong>Perregistravimo data: <\/strong>2008-03-06<\/p>\n<p><strong>Registracijos \u0161alis: <\/strong>Austrija<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Human coagulation factor VIII (inhibitor bypassing fraction) Baxalta [FEIBA] sud\u0117tyje yra: VIII koaguliacijos faktoriaus antiinhibitoriaus-koagulianto kompleksas &#8211; 500 V milteliai ir tirpiklis injekciniam ar infuziniam tirpalui. Preparatas skirtas vartoti leisti \u012f ven\u0105. Receptinis preparatas. Pakuot\u0119 sudaro milteliai, flakonas tirpiklio (10 ml), (BaxJect komplektas, injekcin\u0117 adata, injekcinis \u0161virk\u0161tas, \u201cpeteli\u0161k\u0117s\u201c tipo adata su spaustuku), N1, milteliai, flakonas tirpiklio (10 ml), (filtravimo adata, perpylimo adata, aeracijos adata, injekcin\u0117 adata, injekcinis \u0161virk\u0161tas, \u201cpeteli\u0161k\u0117s\u201c tipo adata su spaustuku), N1 flakonas<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69,2608,2609,4,5],"tags":[186,2610,1246,119,2611],"class_list":["post-25110","post","type-post","status-publish","format-standard","hentry","category-biologinis","category-human-coagulation-factor-viii-inhibitor-bypassing-fraction-baxalta-feiba","category-human-coagulation-factor-viii-inhibitor-bypassing-fraction-baxalta-feiba-500-v","category-vaistai","category-vaistinis-preparatas-vaistai","tag-biologinis","tag-human-coagulation-factor-viii-inhibitor-bypassing-fraction-baxalta-feiba","tag-milteliai-ir-tirpiklis-injekciniam-ar-infuziniam-tirpalui","tag-receptinis","tag-viii-koaguliacijos-faktoriaus-antiinhibitoriaus-koagulianto-kompleksas"],"_links":{"self":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/25110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/comments?post=25110"}],"version-history":[{"count":2,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/25110\/revisions"}],"predecessor-version":[{"id":46584,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/posts\/25110\/revisions\/46584"}],"wp:attachment":[{"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/media?parent=25110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/categories?post=25110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgyd.lt\/cc\/wp-json\/wp\/v2\/tags?post=25110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}